GPP

Great Point Partners Portfolio holdings

AUM $308M
1-Year Est. Return 183.85%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+183.85%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$607M
AUM Growth
-$499M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
46
New
Increased
Reduced
Closed

Top Buys

1
+$25.5M
2
+$14.9M
3
+$14.8M
4
OCUL icon
Ocular Therapeutix
OCUL
+$12.7M
5
MRSN
Mersana Therapeutics
MRSN
+$10.8M

Top Sells

1
+$117M
2
+$111M
3
+$64.4M
4
ACAD icon
Acadia Pharmaceuticals
ACAD
+$59.6M
5
CYTK icon
Cytokinetics
CYTK
+$55.2M

Sector Composition

1 Healthcare 93.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
26
$8.04M 1.32%
5,055,189
-4,630,339
27
$4.44M 0.73%
+64,345
28
$4.24M 0.7%
+75,000
29
$3.24M 0.53%
+70,000
30
$2.42M 0.4%
175,000
-2,310,327
31
$578K 0.1%
1,385
-4,656
32
– –
-155,717
33
– –
-328,817
34
– –
-2,549,525
35
– –
0
36
– –
-446,097
37
– –
-999,422
38
– –
-594,750
39
– –
-1,189,607
40
– –
-1,589,724
41
– –
-1,600,000
42
– –
-2,655,763
43
– –
-70,121
44
– –
-253,230
45
– –
-943,339
46
– –
-435,000
1
2